Alfa Thermodiagnostics

What Alfa Thermodiagnostics does

Alfa Thermodiagnostics, Inc. is a privately held medical-device company founded in 2002 by Dr. Daniel Beilin and headquartered in Aptos, California. The company designs, manufactures, and sells the AlfaSight 9000, an FDA 510(k)-cleared, ISO-13485-certified adjunct diagnostic system that uses infrared sensors to measure skin temperatures at 120 body points before and after a cool-air stress test, then applies proprietary mathematical pattern-recognition algorithms to detect physiological dysfunctions associated with inflammatory, neoplastic, infectious, and musculoskeletal conditions. The technology is positioned as Regulation Thermometry — a refinement of Regulation Thermography — and is intended to identify early physiological changes potentially years before conventional imaging detects pathology.

The AlfaSight 9000 is sold via a direct enterprise sales motion to integrative-medicine, naturopathic, functional-medicine, biological-dentistry, and acupuncture/TCM practitioners, with revenue generated primarily through one-time hardware sales supplemented by the Alfa Advanced Certification Courses (AACC) training program and ongoing practitioner support through the Thermometry Learning Community. End-customer clinics monetize the device by charging patients $225–$650 per scan, with stated throughput of up to 10 scans per day. Adoption is anchored by a Medical Advisory Team of internationally recognized clinicians (including Paracelsus Klinik and Sophia Health Institute), and the company cites an installed base of approximately 180 medical centers across 24 countries and 50,000+ patient evaluations over the technology's history.

Operationally, Alfa Thermodiagnostics remains a small, founder-led, bootstrapped private company with no disclosed institutional funding, no public revenue, and a staff in the 11–50 range. Strategic emphasis is on content-driven demand generation, practitioner certification, and international channel build-out rather than mass-market distribution, leaving the business positioned as a niche leader in alternative and integrative diagnostic adjuncts rather than a scaled conventional medical-device franchise.

Name

Alfa Thermodiagnostics

Legal name

Alfa Thermodiagnostics, Inc.

Website

https://alfathermo.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

Alfa Thermodiagnostics manufactures the FDA-cleared AlfaSight 9000, an infrared thermometry system that analyzes 120 body points to detect early physiological dysfunctions. It sells directly to integrative, naturopathic, biological-dentistry, and TCM practitioners across 24 countries.

Ownership category

akta.pro rank

Product category

Medical Thermometry Devices

NAICS

Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables (334513), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Industrial Instruments For Measurement, Display, And Control (3823), Laboratory Analytical Instruments (3826)

akta.pro industry

PRIMARYHLAHACAK

Continuous Temperature & Fever Monitoring (Wearable Thermometry)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics

SECONDARYCRACAQAG

Thermometers & Temperature Monitoring (Smart Thermometers)

Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)

Keywords

• Medical thermometry devices
• Infrared diagnostic imaging
• Adjunct diagnostic equipment
• Regulation thermometry systems
• Non-invasive medical scanners

Headquarters

HQ city

Aptos

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales

Revenue model

1. AlfaSight 9000 Device Sales: Sale of the AlfaSight 9000 medical diagnostic device to healthcare practitioners, clinics, and hospitals. The device is a Class I prescription medical device with ISO-13485 certification.
2. Per-Test Revenue for Practitioners: Healthcare providers charge patients $225 to $650 per scan. Practices can perform up to 10 scans per day, generating approximately $2000+ per day in potential revenue.
3. Training and Certification: Alfa Advanced Certification Courses (AACC) provided to practitioners. For limited time, included FREE with new AlfaSight purchase for one team member.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Core offering

Alfa Thermodiagnostics manufactures and sells the AlfaSight 9000, an FDA 510(k) cleared whole-body thermometry system that uses a non-contact infrared sensor to scan 120 body points before and after cool-air stress. Proprietary mathematical pattern recognition algorithms interpret the temperature data to identify physiological dysfunctions and disease-contribution patterns, including breast abnormalities and neoplastic conditions. The company also delivers the AACC practitioner certification program supporting device deployment in clinical settings.

Product overview

Alfa Thermodiagnostics offers the AlfaSight 9000 as its primary flagship product - an FDA-cleared whole-body thermometry diagnostic system that uses proprietary infrared sensor technology and mathematical pattern recognition algorithms to provide adjunct diagnostics. The company also provides the AlfaSight Reporting Software as an integral component for analysis and report generation, along with AACC (Alfa Advanced Certification Courses) for practitioner training and competency certification. The system is designed for use by integrative physicians, naturopaths, chiropractors, and biological dentists to detect early physiological dysfunctions up to 5 years before identifiable disease.

Differentiator

Problem solved

Functional benefit

Brands

• AlfaSight 9000: FDA-cleared whole-body adjunct diagnostic device utilizing Regulation Thermometry technology for early detection of physiological dysfunctions.

Products and services

• AlfaSight 9000 Thermometry System FDA 510(k) cleared Class I prescription whole-body adjunct diagnostic device for healthcare professionals; uses an infrared sensor to measure 120 body points before and after cool-air stress and applies proprietary pattern recognition algorithms to detect physiological dysfunctions, inflammatory and neoplastic conditions, breast abnormalities, thyroid issues, vascular disease, and dental-systemic correlations.
• AACC - Alfa Advanced Certification Courses Comprehensive certification program for AlfaSight practitioners and technicians covering thermometry analysis and interpretation; includes certificates of competency, weekly case review webinars, and 1:1 coaching with Dr. Beilin.

Quantifiable outcome

• Detection capability of physiological changes up to 5 years in advance of identifiable disease
• +4 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Breast Thermography International (ITI): ITI provides thermography services and equipment focused specifically on breast health screening, overlapping with AlfaSight's breast health customer segment. It is a smaller, more narrowly focused emerging player in the same niche.
• Real Imaging: Real Imaging developed the MIRA (Multi-Parametric Intelligent Reporting Analysis) system, a radiation-free, non-invasive breast cancer risk assessment device. It overlaps with AlfaSight's value proposition of radiation-free breast screening, though via a different underlying technology.
• Tempdrop: Tempdrop makes a wearable temperature sensor primarily for fertility tracking, overlapping with Alfa's broader temperature-monitoring technology theme but in a consumer wellness use case rather than clinical diagnostics.
• Ava: Ava is a women's health wearable company using continuous temperature (among other sensors) for fertility tracking. It is a thematic adjacent player in continuous skin-temperature monitoring, sharing the temperature-as-health-signal paradigm with AlfaSight.

Broad incumbents

• FLIR Systems (Teledyne FLIR): Teledyne FLIR is a broad incumbent in infrared imaging hardware, including thermal cameras used by clinicians and thermographers. It is an upstream/adjacent player whose general-purpose thermal cameras are sometimes repurposed for clinical thermography, competing loosely with AlfaSight's proprietary dual-cleared sensors.
• Vaso Corporation (VasoHealthcare): Vaso Corporation is a medical technology company with a focus on imaging and diagnostic equipment distribution. As a broader incumbent in the medical imaging space, it represents an adjacent peer that could potentially bundle or compete with specialty diagnostic devices like AlfaSight.
• Hologic: Hologic is a major incumbent in women's health imaging, with its Genius 3D Mammography system being the dominant modality in breast cancer screening. As a broader incumbent, it competes indirectly by defining the clinical standard AlfaSight is positioned against as an adjunct.
• iCAD: iCAD provides AI-powered breast imaging analytics (ProFound AI) for mammography. It is a broad incumbent in breast cancer detection technology that competes for clinical mindshare and reimbursement dollars in the same downstream screening workflows.

Direct peers

• Infrared Sciences Corp. Infrared Sciences Corp. develops and distributes medical infrared thermal imaging cameras (e.g., Sentinel BreastScan) used by clinicians for adjunct breast screening. It competes with AlfaSight in the same adjunct thermography category, serving similar practitioners.
• Meditherm: Meditherm manufactures infrared thermography cameras (Med2000) marketed for medical and clinical screening applications, including breast health. It is the most directly comparable US-based competitor in medical infrared thermometry, targeting a similar integrative and alternative medicine customer base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/AlfaThermodiag1
• LinkedInlinkedin.com/company/alfathermo

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alfa Thermodiagnostics